FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055452511> ?p ?o ?g. }

• W2055452511 endingPage "157" @default.
• W2055452511 startingPage "151" @default.
• W2055452511 abstract "New anticoagulants: how many of our anticoagulated patients can take them? Objective. To establish the percentage of patients with non-valvular atrial fibrillation (AF) on Oral Anticoagulant Therapy subject to new oral anticoagulants, and in how many of them the change would be cost-effective. Material and Methods. Observational, descriptive and cross-sectional study in the area of primary care (Centro de Salud de Manzanares II) on 94 patients (52 males and 42 female) with “anticoagulation” and atrial fibrillation (AF) risk factor by the collection of clinical history (sociodemographic, clinical analytical) data and application of CHADS2 y CHAD2DS2-VASc scores, assessing prescription based on scores. Results. 92,5% are over 65 years of age and 66% over 75. There is a very high rate of High Blood Pressure (78,7%), Diabetes Mellitus (41,4%), Chronic Kidney Disease (34%), Heart Failure (26,5%) and Thrombopenia (11,7%). 4,2% have a glomerular filtration below 30 ml/min and 12,7% between 30-50 ml/min. Out of those over 65, 67% have High Blood Pressure, 35,1% Diabetes Mellitus and 21,2%, Heart Disease. CHADS2 scale values (2,46±1.27 points) with ≥2 points (76,5%). They take drugs with a possible interaction (amiodarone or verapamil) of 5,3%. The INR is at <60% of Therapeutic Range Time at 40,2% (IC95%: 30,4-51,0) of patients which, coupled with the CHADS2 values (1, 2 or ≥3 points: 5,3%, 10.6 y 17% respectively), makes the new anticoagulant cost-effective in 32,9% of patients. Conclusions. The new oral anticoagulants could be indicated in up to two out of three patients with non-valvular AF. They would be contraindicated in 4% of cases, and precaution is necessary in one out of eight patients, due to impaired renal function. Its use would be cost-effective in up to one out of three patients." @default.
• W2055452511 created "2016-06-24" @default.
• W2055452511 creator A5036889823 @default.
• W2055452511 date "2012-10-01" @default.
• W2055452511 modified "2023-09-30" @default.
• W2055452511 title "Nuevos anticoagulantes: ¿cuántos de nuestros pacientes anticoagulados pueden tomarlos?" @default.
• W2055452511 cites W1975440291 @default.
• W2055452511 cites W1992310632 @default.
• W2055452511 cites W1993614294 @default.
• W2055452511 cites W2011936209 @default.
• W2055452511 cites W2062786076 @default.
• W2055452511 cites W2090462746 @default.
• W2055452511 cites W2115010731 @default.
• W2055452511 cites W2119221555 @default.
• W2055452511 cites W2127985968 @default.
• W2055452511 cites W2136489990 @default.
• W2055452511 cites W2154847547 @default.
• W2055452511 cites W84608388 @default.
• W2055452511 doi "https://doi.org/10.4321/s1699-695x2012000300002" @default.
• W2055452511 hasPublicationYear "2012" @default.
• W2055452511 type Work @default.
• W2055452511 sameAs 2055452511 @default.
• W2055452511 citedByCount "0" @default.
• W2055452511 crossrefType "journal-article" @default.
• W2055452511 hasAuthorship W2055452511A5036889823 @default.
• W2055452511 hasBestOaLocation W20554525111 @default.
• W2055452511 hasConcept C126322002 @default.
• W2055452511 hasConcept C127413603 @default.
• W2055452511 hasConcept C134018914 @default.
• W2055452511 hasConcept C159641895 @default.
• W2055452511 hasConcept C164705383 @default.
• W2055452511 hasConcept C23131810 @default.
• W2055452511 hasConcept C2778205648 @default.
• W2055452511 hasConcept C2779161974 @default.
• W2055452511 hasConcept C2780645631 @default.
• W2055452511 hasConcept C555293320 @default.
• W2055452511 hasConcept C71924100 @default.
• W2055452511 hasConcept C78519656 @default.
• W2055452511 hasConcept C84393581 @default.
• W2055452511 hasConceptScore W2055452511C126322002 @default.
• W2055452511 hasConceptScore W2055452511C127413603 @default.
• W2055452511 hasConceptScore W2055452511C134018914 @default.
• W2055452511 hasConceptScore W2055452511C159641895 @default.
• W2055452511 hasConceptScore W2055452511C164705383 @default.
• W2055452511 hasConceptScore W2055452511C23131810 @default.
• W2055452511 hasConceptScore W2055452511C2778205648 @default.
• W2055452511 hasConceptScore W2055452511C2779161974 @default.
• W2055452511 hasConceptScore W2055452511C2780645631 @default.
• W2055452511 hasConceptScore W2055452511C555293320 @default.
• W2055452511 hasConceptScore W2055452511C71924100 @default.
• W2055452511 hasConceptScore W2055452511C78519656 @default.
• W2055452511 hasConceptScore W2055452511C84393581 @default.
• W2055452511 hasIssue "3" @default.
• W2055452511 hasLocation W20554525111 @default.
• W2055452511 hasLocation W20554525112 @default.
• W2055452511 hasOpenAccess W2055452511 @default.
• W2055452511 hasPrimaryLocation W20554525111 @default.
• W2055452511 hasVolume "5" @default.
• W2055452511 isParatext "false" @default.
• W2055452511 isRetracted "false" @default.
• W2055452511 magId "2055452511" @default.
• W2055452511 workType "article" @default.